ALERTS & COVID-19 UPDATES Learn more: COVID-19 Resources; COVID-19 Testing; Vaccine Info; Visitor Policy; Support Us

[LCID Study Number: 2016-079]

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

The primary objective of this study is to compare the effect of a supervised weight loss intervention plus health education materials versus health education materials alone upon invasive disease free survival in overweight and obese women diagnosed with HER-2 negative, stage II and III breast cancer.Researchers will explore the relationship between changes in weight and invasive disease free survival and the interaction between the level of clinical benefit from the weight loss and the intervention.

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2734